Bone Densitometry
www.ISCD.org
2
Introduction
Copyright
• Slides with the ISCD logo in the lower left corner
are copyright © 2006 ISCD, and have been
reviewed and approved by the ISCD Scientific
Advisory Committee
• These ISCD slides may be reproduced and used
for any non-commercial educational purpose
• The ISCD logo must be removed, hidden, or
covered on any slides that are altered, edited or
added to the slide set
4
Disclaimer
• ISCD slides are educational in nature and do not
constitute a medical or professional service
• Every effort has been made to assure that the
information provided is timely and accurate
• Due to the rapidly changing nature of the field,
some information presented may be outdated by
subsequent developments
• The ISCD shall not be held liable or responsible
to any person or entity for any loss or damage
alleged to be caused directly or indirectly by
information contained in these slides
5
Outline
• What is bone density testing?
• Why is it done?
• Who should be tested?
• When should it be repeated?
• How is it interpreted?
6
Definition of Osteoporosis
“A skeletal disorder characterized by
compromised bone strength predisposing to an
increased risk of fracture. Bone strength
reflects the integration of two main features:
bone density and bone quality. Bone quality
refers to architecture, turnover, damage
accumulation (e.g., microfractures), and
mineralization.”
Bone Densitometry
• Non-invasive test for measurement of BMD
• Major technologies
– Dual-energy X-ray Absorptiometry (DXA)
– Quantitative Ultrasound (QUS)
– Quantitative Computerized Tomography (QCT)
• Many manufacturers
• Numerous devices
• Different skeletal sites
9
DXA
• “Gold-standard” for BMD measurement
• Measures “central” or “axial” skeletal sites: spine
and hip
• May measure other sites: total body and forearm
• Extensive epidemiologic data
• Correlation with bone strength in-vitro
• Validated in many clinical trials
• Widely available (about 15,000 DXA machines in
USA)
10
DXA Technology
Detector (detects 2 tissue types - bone and soft tissue)
Photons Collimator
(pinhole for pencil beam, slit for fan beam)
X-ray Source
(produces 2 photon energies with different attenuation profiles)
11
• To diagnose osteoporosis
• To predict fracture risk
• To monitor therapy
12
T-score
Patient’s BMD – Young-Adult Mean BMD
1 SD of Young-Adult Mean BMD
Example:
0.7 g/cm2 - 1.0 g/cm2
T-score = = - 3.0
0.1 g/cm2
16
Z-score
Patient’s BMD – Age-Matched Mean BMD
1 SD of Age-Matched Mean BMD
Classification T-score
Diagnosis Caveats
• T-score -2.5 or less does not always mean
osteoporosis
– Example: osteomalacia
• Clinical diagnosis of osteoporosis may be
made with T-score greater than -2.5
– Example: atraumatic vertebral fracture with T-
score = -1.9
• Low T-score does not identify the cause
– Medical evaluation should be considered
– Example: celiac disease with malabsorption
19
T-score Discordance
• Different skeletal sites have different peak bone
mass at different times and lose bone at different
rates
• Different technologies
• Different regions on interest (ROIs)
• Different reference databases have different
means and SD (the hip is the only skeletal site
with a standardized reference database used by
all manufacturers – National Health and Nutrition
Examination Survey III)
23
Fracture Risk Doubles
With Every SD Decrease in BMD
35
30
25
Relative
Risk 20
for 15
Fracture 10
5
0
-5.0 -4.0 -3.0 -2.0 -1.0 0.0 1.0
Bone Density (T-score)
24
50 80
70
40
Ten Year 30 60
Fracture
Probability 20 50
(%)
10
0
1.0 0.5 0.0 -0.5 -1.0 -1.5 -2.0 -2.5 -3.0 -3.5 -4.0
Femoral Neck T-score
Probability of first fracture of hip, distal forearm, proximal humerus, and
symptomatic vertebral fracture in women of Malmö, Sweden.
Adapted from Kanis JA et al.
Osteoporosis Int. 2001;12:989-995.
25
Treatment Guidelines
Summary of recommendations for pharmacologic therapy according to T-
score from the National Osteoporosis Foundation (NOF) and the American
Association of Clinical Endocrinologists (AACE)
NOF AACE
ISCD
• The International Society for Clinical
Densitometry is a nonprofit professional
society established in 1993 to educate,
certify and establish standards in the field
of bone densitometry
• The ISCD does not endorse any company
or product involved with bone density
testing or the treatment of osteoporosis
• There are over 6,000 clinician and
technologist members worldwide
38
ISCD Certification
• Personal recognition of bone densitometry
skills
• Demonstration of proficiency in bone
densitometry for colleagues and managed
care organizations
• Marketing advantage for centers with
certified staff
• Required for reimbursement by some
managed care organizations
Quality Bone Mineral
Density Testing
www.ISCD.org
ISCD
www.ISCD.org